These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Effect of glucocorticosteroids on the immunological indices of diffuse toxic goiter patients]. Epishin AV Vrach Delo; 1984 Jul; (7):41-3. PubMed ID: 6332424 [No Abstract] [Full Text] [Related]
28. [Correction of immunologic reactivity in elderly patients with diffuse toxic goiter]. Epishin AV; Epishina NA Sov Med; 1990; (2):68-70. PubMed ID: 2356533 [No Abstract] [Full Text] [Related]
29. [Immunocorrective therapy of pyelonephritis in children]. Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860 [TBL] [Abstract][Full Text] [Related]
30. [The efficacy of immunomodulating preparations in treating patients with chronic cholestatic liver diseases]. Radchenko VG; Mitrofanova TI; Serebriakova VI; Vinogradova GL Lik Sprava; 1992; (11-12):38-41. PubMed ID: 1292217 [TBL] [Abstract][Full Text] [Related]
31. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism]. Mel'nik VP Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943 [TBL] [Abstract][Full Text] [Related]
32. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug]. Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615 [No Abstract] [Full Text] [Related]
33. [Principles of immunocorrective therapy using the thymus preparation T-activin]. Arion VIa; Ivanushkin EF Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205 [No Abstract] [Full Text] [Related]
34. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema]. Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765 [TBL] [Abstract][Full Text] [Related]
35. [Levamisole in the combined treatment of patients with ischemic heart disease]. Gorb GD; Makovskaia TE; Tsybul'nik ZI; Grushko IV; Eremeev VS Vrach Delo; 1988 Aug; (8):38-40. PubMed ID: 3264642 [No Abstract] [Full Text] [Related]
36. [The use of taktivin for modulating the functional activity of the neutrophilic granulocytes in patients with systemic lupus erythematosus]. Romanov VA; Borodin AG; Krylov VL Ter Arkh; 1992; 64(5):65-9. PubMed ID: 1455381 [TBL] [Abstract][Full Text] [Related]
37. [Effectiveness of immunotropic preparations in chronic bronchitis]. Sil'vestrov VP; Karaulov AV; Martsinovskiĭ VIu; Semin SN; Ogarkov VI Ter Arkh; 1988; 60(3):42-5. PubMed ID: 2968678 [No Abstract] [Full Text] [Related]
38. [The efficacy of immunomodulating therapy in rheumatoid arthritis]. Bassam B; Balabanova RM Ter Arkh; 1990; 62(5):32-5. PubMed ID: 2204139 [No Abstract] [Full Text] [Related]
39. [Basis of immunocorrective therapy among patients with chronic osteomyelitis]. Sachek MG; Novikov DK; Bulavkin VP Vestn Khir Im I I Grek; 1986 Mar; 136(3):51-3. PubMed ID: 3487867 [TBL] [Abstract][Full Text] [Related]
40. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin]. Matiashina GI Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]